ClinChoice
Jianming (James) Liu has over two decades of experience in quality, regulatory affairs, pharmacovigilance, and project management within the pharmaceutical industry. Starting as an Analytical Chemist at Merck, Jianming (James) has worked their way up to Vice President at ClinChoice, where Jianming (James) leads global quality management, regulatory affairs, and pharmacovigilance. With a strong educational background in chemistry and engineering, Liu has a proven track record of integrating quality systems, handling sponsor and regulatory inspections, and driving new business development. Jianming (James) is a strategic thinker and a valuable asset to any organization Jianming (James) works with.
ClinChoice
2 followers
ClinChoice is a full-service global clinical CRO dedicated to offering high-quality, efficient and flexible solutions to pharmaceutical, biotechnology, medical device, and consumer products clients worldwide. With a 25 year history of success, ClinChoice continues to be The Standard of Excellence for biostatistics, clinical operations, data management, statistical programming, CDISC, regulatory affairs, medical affairs and pharmacovigilance. ClinChoice has established major delivery centers across US, China, Europe, Canada, India, Japan and the Philippines. It has over 4,000 employees globally, with a strong and talented team, and a growing clinical operations presence in seven countries across Asia, North America and Europe.